155 related articles for article (PubMed ID: 19022058)
1. Anti-VEGF therapies in the clinic.
Meadows KL; Hurwitz HI
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028128
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor therapy for malignant glioma.
Gerstner ER; Sorensen AG; Jain RK; Batchelor TT
Curr Neurol Neurosci Rep; 2009 May; 9(3):254-62. PubMed ID: 19348715
[TBL] [Abstract][Full Text] [Related]
3. Angiostasis-induced vascular normalization can improve photodynamic therapy.
Nowak-Sliwinska P; Wagnières G; van den Bergh H; Griffioen AW
Cell Mol Life Sci; 2010 May; 67(9):1559-60; author reply 1561. PubMed ID: 20155480
[No Abstract] [Full Text] [Related]
4. An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.
Tachibana T; Oyama TG; Yoshii Y; Hihara F; Igarashi C; Shinada M; Matsumoto H; Higashi T; Kishimoto T; Taguchi M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139063
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.
Deryugina EI; Quigley JP
Matrix Biol; 2015; 44-46():94-112. PubMed ID: 25912949
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).
Pysz MA; Foygel K; Rosenberg J; Gambhir SS; Schneider M; Willmann JK
Radiology; 2010 Aug; 256(2):519-27. PubMed ID: 20515975
[TBL] [Abstract][Full Text] [Related]
7. VEGF inhibition: insights from preclinical and clinical studies.
Crawford Y; Ferrara N
Cell Tissue Res; 2009 Jan; 335(1):261-9. PubMed ID: 18766380
[TBL] [Abstract][Full Text] [Related]
8. VEGF-A: a critical regulator of blood vessel growth.
Ferrara N
Eur Cytokine Netw; 2009 Dec; 20(4):158-63. PubMed ID: 20167554
[TBL] [Abstract][Full Text] [Related]
9. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
10. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy.
Bagri A; Berry L; Gunter B; Singh M; Kasman I; Damico LA; Xiang H; Schmidt M; Fuh G; Hollister B; Rosen O; Plowman GD
Clin Cancer Res; 2010 Aug; 16(15):3887-900. PubMed ID: 20554752
[TBL] [Abstract][Full Text] [Related]
12. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
